GlobeNewswire Inc | Sep 30, 2021 09:06AM EDT

September 30, 2021

ROCKAWAY, NJ, Sept. 30, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the Company), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference has been rescheduled to today, September 30, 2021 at 12:40 PM eastern time.

Details for the companys presentation are as follows:

Cantor Fitzgerald Virtual Global Healthcare Conference:Date: Thursday, September 30, 2021Rescheduled Time: 12:40 pm EDTInvestors can register for the conference HERE.

Following the conference a webcast replay of the presentation will be available on the Investor section of the companys website, www.electrocore.com.

About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.For more information, visit www.electrocore.com.

Investors:Rich CockrellCG Capital404-736-3838ecor@cg.capital

or

Media Contact:Jackie DorskyelectroCore908-313-6331Jackie.dorsky@electrocore.com